<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04112277</url>
  </required_header>
  <id_info>
    <org_study_id>2018-A03393-52</org_study_id>
    <nct_id>NCT04112277</nct_id>
  </id_info>
  <brief_title>Observational Prospective Study of Opiate-free Anesthesia for Anterior Total Hip Replacement</brief_title>
  <acronym>ASOPHA</acronym>
  <official_title>Observational Prospective Study of Opiate-free Anesthesia for Anterior Total Hip Replacement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hôpital Privé Sévigné</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hôpital Privé Sévigné</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Opioid-free anesthesia (ATO) is a multimodal anaesthesia combining different analgesic and
      anesthetic modalities thus excluding opiates as an intraoperative. Recent studies have found
      a benefit from the ATO on postoperative rehabilitation and reduced length of hospitalization.

      Periarticular infiltration with a local anesthetic is one of the measures proposed in OFA
      during the PTH.

      PTH remains a painful procedure and the occurrence of morphinic-related side effects in
      sometimes elderly patients is often observed.

      The main objective of this study is to assess the feasibility of ATO in anterior hip
      replacement under general anesthesia with the primary endpoint of morphine consumption
      measured 24 hours after surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Actual">February 25, 2020</completion_date>
  <primary_completion_date type="Actual">February 25, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative morphine consumption</measure>
    <time_frame>24 hours after the procedure</time_frame>
    <description>morphine equivalent [mg]</description>
  </primary_outcome>
  <enrollment type="Actual">100</enrollment>
  <condition>Rehabilitation</condition>
  <condition>Analgesia</condition>
  <condition>Anesthesia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cumulative morphine consumption</intervention_name>
    <description>morphine equivalent [mg] 24 hours after the procedure</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with ASA (American Society of Anesthesiology) I-III for whom a total Hip
        Prosthesis is programmed anteriorly (Hueler Method).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 and 85

          -  ASA (American Society of Anesthesiology) I-III

          -  Total Hip Prosthesis programmed anteriorly

          -  Prior obtaining free and informed written consent .Affiliation or beneficiary of a
             social security scheme. Patients affiliated with or beneficiaries of a social security
             plan and not included in another trial.

        Exclusion Criteria:

          -  Pregnant women or breastfeeding Spinal anesthesia Patient on long-term opiate Body
             Mass Index (BMI) - 20 or 45kg/m2 Incomprehension of the ENS scale Unaccompanied
             cardiac conduction disorder, Adam-Stokes syndrome Preoperative Spontaneous Cardiac
             Frequency - 40 beats/min Left ventricle ejection fraction - 40% Unpaired sleep apnea
             syndrome (OSA) Adult incompetent, adults under guardianship or curatorial or deprived
             of liberty Allergy to one of the protocol products or their excipients:
             levobupivacaine, paracetamol, pregabalin, ketoprofen, dexmedetomidine
             Paracetamol-specific contraindication: hepatocellular deficiency Ketoprofen-specific
             contraindications: creatinine clearance - 60ml/min, ATCD of perforated peptic ulcer,
             heart failure, progressive hemorrhage, asthma associated with ketoprofen use
             Contraindications to nefopam: symptomatic prostate disorders, angle-closing glaucoma,
             epilepsy Participation in another clinical study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hopital Privé Sévigné</name>
      <address>
        <city>Cesson-Sévigné</city>
        <zip>35510</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>September 30, 2019</study_first_submitted>
  <study_first_submitted_qc>October 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 2, 2019</study_first_posted>
  <last_update_submitted>February 25, 2020</last_update_submitted>
  <last_update_submitted_qc>February 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

